Alkem Laboratories (NSE:ALKEM) EV-to-Revenue : 4.72 (As of May. 11, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Alkem Laboratories EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Alkem Laboratories's enterprise value is ₹589,317 Mil. Alkem Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹124,755 Mil. Therefore, Alkem Laboratories's EV-to-Revenue for today is 4.72.

The historical rank and industry rank for Alkem Laboratories's EV-to-Revenue or its related term are showing as below:

NSE:ALKEM' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.69 Med: 3.67 Max: 5.22
Current: 4.72

During the past 13 years, the highest EV-to-Revenue of Alkem Laboratories was 5.22. The lowest was 2.69. And the median was 3.67.

NSE:ALKEM's EV-to-Revenue is ranked worse than
74% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 2.41 vs NSE:ALKEM: 4.72

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-11), Alkem Laboratories's stock price is ₹5128.90. Alkem Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1,043.36. Therefore, Alkem Laboratories's PS Ratio for today is 4.92.

Alkem Laboratories EV-to-Revenue Historical Data

The historical data trend for Alkem Laboratories's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkem Laboratories EV-to-Revenue Chart

Alkem Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-Revenue

Get a 7-Day Free Trial

2.94

3.56

3.82

4.13

3.45

Alkem Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															3.25	3.45	3.55	3.37	4.99

Competitive Comparison of Alkem Laboratories's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Alkem Laboratories's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alkem Laboratories's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkem Laboratories's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Alkem Laboratories's EV-to-Revenue falls into.

Alkem Laboratories EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Alkem Laboratories's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	589317.029	/	124754.5
	=	4.72

Alkem Laboratories's current Enterprise Value is ₹589,317 Mil.
Alkem Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹124,755 Mil.

Alkem Laboratories (NSE:ALKEM) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Alkem Laboratories's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	5128.90	/	1043.363
	=	4.92

Alkem Laboratories's share price for today is ₹5128.90.
Alkem Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,043.36.

Alkem Laboratories EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Alkem Laboratories's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Alkem Laboratories (NSE:ALKEM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkem Laboratories Ltd (NSE:ALKEM) » Definitions » EV-to-Revenue

Traded in Other Exchanges

539523:India

Address

Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013

Website

https://www.alkemlabs.com

Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.

Alkem Laboratories (NSE:ALKEM) Headlines

No Headlines